Session Details

This session will address cardiotoxicities of novel breast cancer therapies, strategies for risk assessment and cardioprotection, and innovative clinical trial approaches to improve cardiac outcomes.

Presentation numberED13-01

Cardiotoxicity of breast cancer novel therapies

Anne H Blaes, University of Minnesota, Minneapolis, MN

Presentation numberED13-02

Approaches for cardioprotection in cancer care

Eric H Yang, UCLA, Los Angeles, CA

Presentation numberED13-03

Trial strategies to optimize cardiac outcomes

Javid Moslehi, University of California San Francisco, San Francisco, CA

Advocate

Aj Veach, Savvy Cooperative, Washington D.C., MD